Dendritic Cells in Esophageal Adenocarcinoma: The Currently Available Information and Possibilities to use Dendritic Cells for Immunotherapeutic Approaches

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|3|307-311

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.3, 2016-01, pp. : 307-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic Cells in Colorectal Cancer and a Potential for their Use in Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 22, Iss. 16, 2016-05 ,pp. : 2431-2438

Bentham Science Publishers

Access to resources Recommend Favorite

Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 2, 2011-06 ,pp. : 154-164

Bentham Science Publishers

Access to resources Recommend Favorite

Use of dendritic cells in drug selection, development and therapy

By Unadkat Jignesh   Feili-Hariri Maryam  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 2, 2008-02 ,pp. : 247-259

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic use of dendritic cells transfected with tumour RNA

By Grünebach Frank   Brossart Peter  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. : 1703-1709

Informa Healthcare

Access to resources Recommend Favorite

Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5873-5882

Bentham Science Publishers

Access to resources Recommend Favorite